Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(21 sites)

Australia

Dept. Cardiothoracic Surgery , Monash Medical Centre, Clayton, Melbourne

Austria

Division of Cardiac Surgery, Department of Surgery, LKH Medical University of Graz, Graz

MedUniWien / AKH-Wien, Vienna

Belgium

Department of Intensive Care, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels

Department of Intensive Care, Hôpital Universitaire de Bruxelles (HUB), Brussels

Hospital ZOL, Genk

Dept. of Anesthesia and Intensive Care, AZ Maria Middelares, Ghent

Jessa Ziekenhuis,Campus Virga Jesse, Hasselt

Germany

German Heart Centre Munich, Dept.Cardio-Vascular Surgery, Munich, Bavaria

Klinik für Herzchirurgie, Universitätsklinik, Leipzig

Italy

U.O.C. Cardiochirurgia e Trapianti di Cuore, Azienda Ospedaliera San Camillo Forlanini, Roma

Policlinico Gemelli, Institute Cardiology, Roma

Malaysia

Institut Jantung Negara (IJN , Natl. Heart Inst.), Kuala Lumpur

Netherlands

Dept. Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, Limburg

Catharina Ziekenhuis, Cathreine R&D, Heartcentre, Eindhoven

Portugal

Hospital de Santa Marta, Lisbon

Russia

State Autonomous Healthcare Institution "Interregional Clinical Diagnostic Center", Kazan'

Federal State Budgetary Military Educational Institution of the Higher Education, Saint Petersburg

Almazov Heart Center, Saint Petersburg

Singapore

National University Hospital (NUH),, Singapore

Spain

Jefe de Servicio de Cirugía Cardiovascular, Hospital Universitario La Princesa, Madrid